首页> Heart rhythm> Competing risks in patients with primary prevention implantable cardioverter-defibrillators: Global Electrical Heterogeneity and Clinical Outcomes study.

Competing risks in patients with primary prevention implantable cardioverter-defibrillators: Global Electrical Heterogeneity and Clinical Outcomes study.

导出 OA

翻译打印收藏纠错

第一作者： Jonathan W,Waks

第一单位： Department of Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

作者： Jonathan W,Waks ^[1] ; Kazi T,Haq ^[2] ; Christine,Tompkins ^[3] ; Albert J,Rogers ^[4] ; Ashkan,Ehdaie ^[5] ; Aron,Bender ^[2] ; Jessica,Minnier ^[2] ; Khidir,Dalouk ^[6] ; Stacey,Howell ^[2] ; Achille,Peiris ^[5] ; Merritt,Raitt ^[6] ; Sanjiv M,Narayan ^[4] ; Sumeet S,Chugh ^[5] ; Larisa G,Tereshchenko ^[7]

作者单位： Department of Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts. ^[1] Department of Medicine, Cardiovascular Division, Oregon Health & Science University, Portland, Oregon. ^[2] Department of Medicine, Cardiovascular Division, University of Colorado, Aurora, Colorado. ^[3] Department of Medicine, Cardiovascular Division, University, Palo Alto, California. ^[4] Department of Medicine, Cardiovascular Division, Cedars-Sinai Health System, Los Angeles, California. ^[5] Department of Medicine, Cardiovascular Division, Portland Health Care System, Portland, Oregon. ^[6] Department of Medicine, Cardiovascular Division, Oregon Health & Science University, Portland, Oregon. Electronic address: tereshch@ohsu.edu. ^[7]

关键词 Competing risk Global electrical heterogeneity Heart failure Implantable cardioverter-defibrillators Ventricular tachycardia/Ventricular fibrillation